Back to top
more

Regencell Bioscience (RGC)

(Delayed Data from NSDQ)

$5.70 USD

5.70
27,232

-0.05 (-0.87%)

Updated Apr 23, 2024 03:53 PM ET

After-Market: $5.40 -0.30 (-5.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Regencell Bioscience Holdings Limited [RGC]

Reports for Purchase

Showing records 1 - 20 ( 371 total )

Company: Regencell Bioscience Holdings Limited

Industry: Medical - Biomedical and Genetics

Record: 1

10/30/2023

Company Report

Pages: 4

1Q Preview: Progress Continues; Reiterate Buy Rating, $2 PT

Provider: SMALL CAP CONSUMER RESEARCH, LLC

Analyst: BEDER E

Price: 5.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 2

02/26/2018

Industry Report

Pages: 29

Movies and Entertainment -Now Playing - at the Movies

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 75.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 3

01/29/2018

Industry Report

Pages: 37

Movies and Entertainment -Now Playing at the Movies

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 75.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 4

01/16/2018

Industry Report

Pages: 33

Movies and Entertainment -Now Playing at the Movies

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 75.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 5

01/08/2018

Daily Note

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 6

01/08/2018

Company Report

Pages: 8

Updating Q4 and Adjusting 2018 Box Office Estimates

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 7

12/06/2017

Daily Note

Pages: 6

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 8

12/05/2017

Company Report

Pages: 8

Downgrading to NEUTRAL on Pending Acquisition

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 9

10/25/2017

Company Report

Pages: 16

Regal Performs Amid Difficult Box Office

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 50.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 10

10/25/2017

Daily Note

Pages: 10

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 11

10/19/2017

Company Report

Pages: 9

Expect Focus to Shift Once Holiday Slate Commences

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 12

10/19/2017

Daily Note

Pages: 9

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 13

10/09/2017

Company Report

Pages: 8

Adjusting Model on Sluggish Summer and Upcoming Slate

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 14

07/27/2017

Daily Note

Pages: 10

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 15

07/27/2017

Company Report

Pages: 17

Expense Management 101: This is How It''s Done

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 50.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 16

07/20/2017

Daily Note

Pages: 9

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 17

07/20/2017

Company Report

Pages: 13

Regal Goes First, and Often Calms Stormy Waters

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 50.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 18

07/10/2017

Daily Note

Pages: 8

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 19

07/10/2017

Company Report

Pages: 9

Weak Summer Release Slate, True... Still Steady as She Goes

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 25.00

Research Provided by a Third Party

Company: Regencell Bioscience Holdings Limited

Industry: Leisure and Recreation Services

Record: 20

06/19/2017

Industry Report

Pages: 22

Now Playing - at the Movies

Provider: WEDBUSH SECURITIES INC.

Analyst: PACHTER M

Price: 75.00

Research Provided by a Third Party